McKesson Corporation vs Yum! Brands, Inc. — how do they compare? McKesson Corporation trades at $938.84 (market cap $108.46B), while Yum! Brands, Inc. trades at $144.82 (market cap $39.02B). The key difference: McKesson Corporation is far larger — about 2.8× Yum! Brands, Inc.'s market cap, and Yum! Brands, Inc. pays the higher dividend (2.1%). Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and Yum! Brands, Inc. for 132 Days on average.
| MCK | YUM | |
|---|---|---|
Market Cap | $108.46B | $39.02B |
Volume | 712,607 | 2,597,636 |
Sector | Health | Consumer Cyclical |
52-Week High | $995.69 | $168.16 |
52-Week Low | $725.17 | $135.77 |
Typical Hold Time | 74 Days | 132 Days |
Enterprise Value | $115.00B | $50.63B |
Dividend Yield | 0.4% | 2.1% |
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $930.25, up 2.19% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q2 2026 EPS of $9.93 exceeding expectations of $9.56. Recent news highlights the extension of McKesson's pharmaceutical distribution agreement with CVS Health through 2032, reinforcing long-term revenue visibility. Revenue growth remains robust, climbing from $264.0B in 2022 to $359.1B in 2025, though net margins are thin at 1.12%.
McKesson presents a favorable risk-reward profile with 81% analyst buy ratings and a $956.43 consensus price target offering 2.8% upside. Key risks include margin pressure from drug pricing dynamics and policy uncertainty. The company's strong cash flow generation ($6.1B operating cash flow in 2025) and strategic focus on oncology and specialty distribution support continued growth, though investors should monitor debt levels and competitive pressures in healthcare distribution.
YUM trades at $143.00, up 1.89% over 24 hours, with a bullish technical signal and strong support at $141. Revenue has grown from $6.8B in 2022 to $8.2B in 2025, with net income reaching $1.56B. Recent news highlights KFC's new Open House restaurant concept in Texas, testing expanded menus and customer experiences.
The outlook remains positive with a consensus price target of $170.44, though risks include high debt levels and competitive pressures. Earnings have beaten expectations in two of the last three quarters, with Q3 2026 results pending. Analyst sentiment is mixed with 39.22% buy ratings, 54.9% hold, and 5.88% sell.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.
Read more on YUM →